Search Grant Opportunities

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)

ID: RFA-DA-23-021 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:

Description

This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research projects, directed towards commercialization, for the development of novel, evidence-based, FDA-regulated medical products addressing the needs of patients suffering from opioid use disorders (OUD) and stimulant use disorders (StUD). Applications received under this FOA may fall within two scientific areas, namely: (1) pharmacotherapeutics (small molecules and biologics; and (2) medical therapeutic and diagnostic devices, including software as a medical device. This FOA strives to contribute to the effort against national opioid and psychostimulant emergency and offer new medical products for individuals, families, and communities affected by this devastating crisis.
Show All

Overview

Agency
National Institutes of Health (NIH) [HHS]
Category of Funding
Education
Health
Funding Instruments
Grant
Grant Program (CFDA)
93.279 - Drug Abuse and Addiction Research Programs
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
Grants.gov
On 3/28/22 the National Institutes of Health posted grant opportunity RFA-DA-23-021 for Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional). The grant will be issued under grant program 93.279 Drug Abuse and Addiction Research Programs.

Timing

Posted Date
March 28, 2022, 12:00 a.m. EDT
Closing Date
Feb. 14, 2025, 12:00 a.m. EST Past Due
Last Updated
March 28, 2022, 2:35 p.m. EDT
Version
1
Archive Date
March 22, 2025

Eligibility

Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Contacts

Contact
National Institutes of Health
Contact Email
oerwebmaster03@od.nih.gov
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information Site
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-021.html

Documents

Posted documents for RFA-DA-23-021

Opportunity Assistant

AI Analysis

Grant Awards

Grants awarded through RFA-DA-23-021

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to RFA-DA-23-021

Experts for Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)

Recommended subject matter experts available for hire